PT88076A - Process for preparing dna vectors of human factor inhibitor - Google Patents

Process for preparing dna vectors of human factor inhibitor

Info

Publication number
PT88076A
PT88076A PT88076A PT8807688A PT88076A PT 88076 A PT88076 A PT 88076A PT 88076 A PT88076 A PT 88076A PT 8807688 A PT8807688 A PT 8807688A PT 88076 A PT88076 A PT 88076A
Authority
PT
Portugal
Prior art keywords
dna vectors
preparing dna
inhibitor factor
human inhibitor
human
Prior art date
Application number
PT88076A
Other languages
English (en)
Other versions
PT88076B (pt
Inventor
George John Broze Jr
Kuniko Kusano Kretzmer
Tze-Chein Wun
Original Assignee
Monsanto Co
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22410671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT88076(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/123,753 external-priority patent/US4966852A/en
Application filed by Monsanto Co, Univ Washington filed Critical Monsanto Co
Publication of PT88076A publication Critical patent/PT88076A/pt
Publication of PT88076B publication Critical patent/PT88076B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT88076A 1987-11-23 1988-07-22 Processo para a preparacao de vectores de dna do inibidor do factor de tecido humano PT88076B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/123,753 US4966852A (en) 1987-07-23 1987-11-23 DNA clone of human tissue factor inhibitor

Publications (2)

Publication Number Publication Date
PT88076A true PT88076A (pt) 1988-08-01
PT88076B PT88076B (pt) 1993-01-29

Family

ID=22410671

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88076A PT88076B (pt) 1987-11-23 1988-07-22 Processo para a preparacao de vectores de dna do inibidor do factor de tecido humano

Country Status (15)

Country Link
EP (1) EP0318451B1 (pt)
JP (5) JP2836823B2 (pt)
KR (1) KR930000274B1 (pt)
AT (1) ATE111518T1 (pt)
AU (1) AU604139B2 (pt)
CA (1) CA1341223C (pt)
DE (1) DE3851511T2 (pt)
DK (1) DK173536B1 (pt)
ES (1) ES2063769T3 (pt)
FI (1) FI93365C (pt)
IE (1) IE65393B1 (pt)
IL (1) IL87171A (pt)
NO (2) NO310466B1 (pt)
NZ (1) NZ225535A (pt)
PT (1) PT88076B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
EP0439442B1 (en) * 1990-01-25 1996-03-06 Washington University Factor x-laci hybrid protein
IE913004A1 (en) * 1990-08-27 1992-03-11 Monsanto Co Anticoagulant combination of laci and sulfated¹polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
AU2002365131B2 (en) 2001-10-15 2007-03-01 Novartis Vaccines And Diagnostics, Inc. Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI)
ATE477020T1 (de) 2002-06-07 2010-08-15 Dyax Corp Prevention und verringerung von ischemia
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
SI1981519T1 (en) 2005-12-29 2018-05-31 Dyax Corp. INHIBITION PROTEAZE
DK2379096T3 (da) 2008-12-19 2019-11-25 Baxalta GmbH TFPI-inhibitorer og fremgangsmåder til anvendelse
US8450275B2 (en) 2010-03-19 2013-05-28 Baxter International Inc. TFPI inhibitors and methods of use
AU2010203712A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
JP6037841B2 (ja) 2010-01-06 2016-12-07 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
RU2013158627A (ru) * 2011-06-15 2015-07-20 Ф. Хоффманн-Ля Рош Аг Антитела к рецептору человеческого эритропоэтина и способы их применения
HUE046572T2 (hu) 2012-03-21 2020-03-30 Baxalta GmbH TFPI inhibitorok és alkalmazási eljárások
CN108602893A (zh) 2015-12-11 2018-09-28 戴埃克斯有限公司 血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington A method of inhibiting the isolation of a purer tissue factor

Also Published As

Publication number Publication date
AU604139B2 (en) 1990-12-06
DE3851511D1 (de) 1994-10-20
NO883270L (no) 1989-05-24
FI93365C (fi) 1995-03-27
JP2002097200A (ja) 2002-04-02
JP2005306875A (ja) 2005-11-04
JPH1175875A (ja) 1999-03-23
DK413488A (da) 1989-05-24
DK173536B1 (da) 2001-02-05
EP0318451A2 (en) 1989-05-31
EP0318451B1 (en) 1994-09-14
JP2004201696A (ja) 2004-07-22
ATE111518T1 (de) 1994-09-15
FI93365B (fi) 1994-12-15
JP2836823B2 (ja) 1998-12-14
EP0318451A3 (en) 1990-03-28
DK413488D0 (da) 1988-07-22
FI883487A (fi) 1989-05-24
JP4025035B2 (ja) 2007-12-19
NO310466B1 (no) 2001-07-09
FI883487A0 (fi) 1988-07-22
IL87171A0 (en) 1988-12-30
IE882243L (en) 1989-05-23
KR890007750A (ko) 1989-07-05
JP3565714B2 (ja) 2004-09-15
IL87171A (en) 1995-08-31
DE3851511T2 (de) 1995-03-30
JPH01165383A (ja) 1989-06-29
NO20013608L (no) 1989-05-24
PT88076B (pt) 1993-01-29
IE65393B1 (en) 1995-10-18
AU1928788A (en) 1989-05-25
ES2063769T3 (es) 1995-01-16
NO883270D0 (no) 1988-07-22
CA1341223C (en) 2001-05-01
NZ225535A (en) 1990-11-27
NO20013608D0 (no) 2001-07-20
KR930000274B1 (ko) 1993-01-14

Similar Documents

Publication Publication Date Title
PT88076A (pt) Process for preparing dna vectors of human factor inhibitor
GR3021708T3 (en) Human vascular permeability factor
PT87754A (pt) Process for the preparation of new amino acid derivatives
GR3021063T3 (en) DNA clone of human thrombomodulin
ZA885370B (en) Dna clone of human tissue factor inhibitor
ES548052A0 (es) Procedimiento para preparar peptidos
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
FI883589A0 (fi) Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi
DK225788A (da) Poroes harpiksfilm og fremmgangsmaade til fremstilling deraf
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
IT8921794A0 (it) Procedimento per la sintesi della 1 n (s delta ammino alfa idrossibutirril)kamanycin a basato sul trattamento della 1 n (s delta benzilossicarnonilamino alfa idrossibutirril) 3,6' di n benzilossicarbonilkanamycin a conacido formico
DE69025689D1 (de) Verfahren zur Herstellung von menschlicher Thiroid-Peroxydase
IT8747738A0 (it) Procedimento per la produzione di (-) n-acetil ammino carnitina e di (+) n-acetil ammino carnitina
IT1243088B (it) Impianto per la produzione di calzature e procedimento per l'impiego di detto impianto
NO882836D0 (no) Fremgangsmaate for kjemisk modifisering av protider (proteiner og peptider).
NO914588L (no) Enzymkatalysert fremgangsmaate for fremstilling av n-acyl-aminosyrer og n-acyl-aminosyreamider
IT8922312A0 (it) Nuovo metodo di trattamento dell'aritmia ventricolare
IT8719433A0 (it) Procedimento per la preparazione di alfafetoproteina umana.
IT1212555B (it) Composizione a base di dobesilato di calcio per il trattamento di malattie cardiache
HRP940444A2 (en) Process for the preparation of unsaturated amino acid compounds
IT1222128B (it) Procedimento per il trattamento di articolo casalinghi e articoli casalinghi trattati cosi' ottenuti
IT8721299A0 (it) Procedimento per l'idrofobizzazione di oggetti di gesso.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920727

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080128

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080722